Literature DB >> 19286442

Platelet glycoprotein IIb/IIIa (HPA-1 and HPA-3) polymorphisms in patients with hemorrhagic fever with renal syndrome.

Zhengwen Liu1, Maicang Gao, Qunying Han, Sai Lou, Jie Fang.   

Abstract

This study investigated the relationship between human platelet alloantigen (HPA) polymorphisms of glycoprotein IIb/IIIa and hemorrhagic fever with renal syndrome (HFRS). HPA-1 and HPA-3 genotyping was performed with allele-specific primer polymerase chain reaction in 104 patients with HFRS and 100 normal individuals as controls. The relationships between gene polymorphisms of HPAs and HFRS and the disease severity were analyzed. The results indicated no significant difference in HPA-1 genotype distributions (p > 0.05), but a significant difference in the distributions of genotype and allele frequencies of HPA-3 between HFRS patients and controls (p < 0.01). The distributions of HPA-3 genotype and allele frequencies differed significantly between patients with different clinical types and the HPA-3 b allele was more frequently observed in patients with more severe clinical types. These results indicate that HPA-3 polymorphism may be one of the inherited risk factors associated with the susceptibility of hantavirus infection and the disease severity of HFRS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286442     DOI: 10.1016/j.humimm.2009.03.009

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  8 in total

1.  Lack of association between integrin αvβ3 gene polymorphisms and hemorrhagic fever with renal syndrome in Han Chinese from Hubei, China.

Authors:  Xiao-Ping Chen; Hai-Rong Xiong; Ni Zhu; Qing-Zhou Chen; Hui Wang; Chao-Jie Zhong; Mei-Rong Wang; Shuang Lu; Fan Luo; Wei Hou
Journal:  Virol Sin       Date:  2017-02-09       Impact factor: 4.327

2.  Polymorphisms of PAI-1 and platelet GP Ia may associate with impairment of renal function and thrombocytopenia in Puumala hantavirus infection.

Authors:  Outi Laine; Lotta Joutsi-Korhonen; Satu Mäkelä; Jussi Mikkelsson; Tanja Pessi; Sari Tuomisto; Heini Huhtala; Daniel Libraty; Antti Vaheri; Pekka Karhunen; Jukka Mustonen
Journal:  Thromb Res       Date:  2011-11-30       Impact factor: 3.944

3.  Andes virus recognition of human and Syrian hamster beta3 integrins is determined by an L33P substitution in the PSI domain.

Authors:  Valery S Matthys; Elena E Gorbunova; Irina N Gavrilovskaya; Erich R Mackow
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

4.  Association of platelet ITGA2B and ITGB3 polymorphisms with ex vivo antiplatelet effect of ticagrelor in healthy Chinese male subjects.

Authors:  Mu-Peng Li; Yan Xiong; An Xu; Ji-Peng Zhou; Jie Tang; Zan-Ling Zhang; Hong-Hao Zhou; Wei Zhang; Xiao-Ping Chen
Journal:  Int J Hematol       Date:  2014-01-29       Impact factor: 2.490

5.  Host genetic factors associated with the range limit of a European hantavirus.

Authors:  Moritz Saxenhofer; Anton Labutin; Thomas A White; Gerald Heckel
Journal:  Mol Ecol       Date:  2021-10-21       Impact factor: 6.622

Review 6.  Immunogenetic factors affecting susceptibility of humans and rodents to hantaviruses and the clinical course of hantaviral disease in humans.

Authors:  Nathalie Charbonnel; Marie Pagès; Tarja Sironen; Heikki Henttonen; Olli Vapalahti; Jukka Mustonen; Antti Vaheri
Journal:  Viruses       Date:  2014-05-26       Impact factor: 5.048

7.  A Single-Nucleotide Polymorphism of αVβ₃ Integrin Is Associated with the Andes Virus Infection Susceptibility.

Authors:  Constanza Martínez-Valdebenito; Jenniffer Angulo; Nicole Le Corre; Claudia Marco; Cecilia Vial; Juan Francisco Miquel; Jaime Cerda; Gregory Mertz; Pablo Vial; Marcelo Lopez-Lastra; Marcela Ferrés
Journal:  Viruses       Date:  2019-02-20       Impact factor: 5.048

8.  Human platelet antigen 1-6, 9 and 15 in the Iranian population: An anthropological genetic analysis.

Authors:  Mohammad Hossein Kazemi; Farideh Malakootikhah; Zahra Momeni-Varposhti; Reza Falak; Ali-Akbar Delbandi; Nader Tajik
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.